Activation of human neutrophils by mycobacterial phenolic glycolipids

Clinical and Experimental Immunology

Volumn 118, Issue 2, 1999, Pages 253-260

  Faldt J ^b   Dahlgren, C ^b   Karlsson, A ^b   Ahmed, A M S ^a   Minnikin, D E ^a   Ridell, M ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Carbohydrate moiety; Mycobacterium; Oxygen radicals; Phagocyte

Indexed keywords

FUCOSE; PHENOLIC GLYCOLIPID; REACTIVE OXYGEN METABOLITE; RHAMNOSE;

ARTICLE; CARBOHYDRATE ANALYSIS; CELLULAR DISTRIBUTION; CHEMOLUMINESCENCE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL;

ANTIGENS, BACTERIAL; CARBOHYDRATE METABOLISM; CARBOHYDRATES; COMPLEMENT INACTIVATOR PROTEINS; CYTOPLASMIC GRANULES; CYTOSKELETON; ENZYME INDUCTION; GLYCOLIPIDS; HUMANS; MACROPHAGE-1 ANTIGEN; MONOSACCHARIDES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NADPH OXIDASE; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 0242620203     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01040.x     Document Type: Article

References (48)

1. 1 Rook GAW, Bloom BR. Mechanism of pathogenesis in tuberculosis. In: Bloom BR, ed. Tuberculosis. Washington, DC: ASM Press, 1994:485-501.
2. 2 Rivière M, Fourniè JJ, Puzo G. A novel mannose containing phenolic glycolipid from Mycobacterium kansasii. J Biol Chem 1987; 262:14879-84.
3. 3 Hartmann S, Minnikin DE. Mycobacterial phenolic glycolipids. In: Tyman JHP, ed. Surfactants in lipid chemistry. Cambridge: Royal Society of Chemistry, 1992:135-58.
4. 4 Daffé M, Lacave C, Laneelle MA, Laneelle G. Structure of the major triglycosyl phenol-phthiocerol of Mycobacterium tuberculosis (strain Canetti). Eur J Biochem 1987; 167:155-60.
5. 5 Minnikin DE, Dobson G, Parlett JH, Goodfellow M, Magnusson M. Analysis of dimycocerosates of glycosyl phenolphthiocerols in the identification of some clinically significant mycobacteria. Eur J Clin Microbiol 1987; 6:703-7.
6. 6 Fournie' JJ, Rivie're M, Puzo G. Absolute configuration of the unique 2,6-dideoxy-4-O-methyl-arabino-hexopyranose of the major phenolic glycolipid antigen from Mycobacterium kansasii. Eur J Biochem 1987; 168:181-3.
7. 7 Daffé M, Lanéelle MA, Lacave C, Lanéelle G. Monoglycosyldiacylphenol-phthiocerol of Mycobacterium tuberculosis and Mycobacterium bovis. Biochim Biophys Acta 1988; 958:443-9.
8. 8 Ridell M, Wallerström G, Minnikin DE, Bolton RC, Magnusson M. A comparative serological study of antigenic glycolipids from Mycobacterium tuberculosis. Tuber Lung Dis 1992; 73:101-5.
9. 9 Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984; 2:283-318.
10. 10 Brown AE, Holzer TJ, Andersen BR. Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis 1987; 156:985-91.
11. 11 Riedel DD, Kaufmann SIIE. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun 1997; 65:4620-3.
12. 12 Silva MT, Nazare' M, Silva T, Appelberg R. Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microb Pathogen 1989; 6:369-80.
13. 13 Gallin JI, Goldstein IM, Snyderman R. Inflammation basic principles and clinical correlates. New York: Raven Press 1992.
14. 14 Zhang L, Goren MB, Holzer TJ, Andersen BR. Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells. Infect Immun 1988; 56:2876-83.
15. 15 Zhang L, English D, Andersen BR. Activation of human neutrophils by Mycobacterium tuberculosis derived sulfolipid-1. J Immunol 1991; 146:2730-6.
16. 16 Zhang L, Gay JC, English D, Andersen BR. Neutrophil priming mechanisms of sulfolipid-I and N-formyl-methionyl-leucyl-phenylalanine. J Biomed Sci 1994; 1:253-62.
17. 17 Geertsma MF, Nibbering PH, Pos O, Van Furth R. Interferon-γ-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol 1990; 20:869-73.
18. 18 Dobson G, Minnikin DE, Besra GS, Mallet AI, Magnusson M. Characterisation of phenolic glycolipids from Mycobacterium marinum. Biochim Biophys Acta 1990; 1042:176-81.
19. 19 Dobson G, Minnikin DE, Minnikin SM, Parlett JH, Goodfellow M, Ridell M, Magnusson M. Systematic analysis of complex mycobacterial lipids. Chem Meth Bact Syst; London: Academic Press, 1985; 237-65.
20. 20 Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 97:77-89.
21. 21 Allen RC, Loose LD. Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun 1976; 69:245-52.
22. 22 Dahlgren C, Follin P, Johansson A, Lock R, Orselius K. Localization of the luminol-dependent chemiluminoscence reaction in human granulocytes. J Biochem Chemilum 1989; 4:263-6.
23. 23 Dahlgren C, Follin P, Johansson A, Lock R, Lundqvist H, Walan . Chemiluminescence as a means of following the function of phagocytic cells. Trends Photochem Photobiol 1991; 2:427-43.
24. 24 Lundqvist H, Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med 1996; 20:785-92.
25. 25 Vann WF, Jann K. Structure and serological specificity of the. K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli. Infect Immun 1979; 25:85-92.
26. -. Eur J Biochem 1983; 131:509-17.
27. 27 Sehgal G, Zhang K, Todd RF III, Boxer LA, Petty HR. Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. J Immunol 1993; 150:4571-80.
28. 28 Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993; 150:2920-30.
29. 29 Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 1994; 152:4070-9.
30. 30 Schlesinger LS, Kaufman TM, Iyver S, Hull SR, Marchiando LK. Differences in mannose receptor-mediated uptake of lipoarahinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 1996; 157:4568-75.
31. 31 Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the suger specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 1996; 156:1235-46.
32. 32 Wright SD, Levin SM, Jong MT, Chad Z, Kabbash LGCR, 3 (CD11b/ CD18): expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 1989; 169:175-83.
33. 33 Herrmann M, Jaconi MEE, Dahlgren C, Waldvogel FA, Stendahl O, Lew DP. Neutrophil bactericidal activity aganist Staphylococcus aureus adherent on biological surfaces. J Clin Invest 1990; 86:942-51.
34. 34 Tauber AI, Karnad AB, Hartshorn KL, Myers JB, Schwartz JH. Parameters of neutrophil activation: models of priming and deactivation. Prog Clin Biol Res 1989; 297:297-309.
35. 35 Sengeløv H, Follin P, Kjeldsen K, Lollike K, Dahlgren C, Borregaard N. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995; 154:4157-65.
36. 2+ level and action of phorbol myristate acetate. J Clin Invest 1987; 79:1226-33.
37. 37 Karlsson A, Follin P, Leffler H, Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood 1998; 91:3430-8.
38. 38 Lundqvist H, Gustafsson M, Johansson A, Särndahl E, Dahlgren C. Neutrophil control of formylmethionyl-leucyl-phenylalanine induced mobilization of secretory vesicles and NADPH-oxidase activation: effect of an association of the ligand-receptor complex to the cytoskeleton. Biochim Biophys Acta 1994; 1224:43-50.
39. 39 Hirsch CS, Ellner JJ, Russell DG, Rich EA. Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994; 152:743-53.
40. 40 Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J 1995; 9:200-9.
41. 41 Babior BM. The respiratory burst oxidase and the molecular basis of chronic granulomatous disease. Am J Hematol 1991; 37:263-6.
42. 42 Dahlgren C, Johansson A, Lundqvist H, Bjerrum OW, Borregaard N. Activation of the oxygen-radical-generating system in granules of intact human neutrophils by a calcium ionophore (ionomycin). Biochim Biophys Acta 1992; 1137:182-8.
43. 43 Cywes C, Godenir NL, Hoppe HC, Scholle RR, Steyn LM, Kirsch RE, Ehlers MR. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect Immun 1996; 64:5373-883.
44. 44 Cywes C, Hoppe HC, Daffe' M, Ehlers MRW. Nonopsinic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun 1997; 65:4258-66.
45. 45 Liu L, Elwing H, Karlsson A, Nimeri G, Dahlgren C. Surface-related triggering of the neutrophil respiratory burst. Characterization of the response induced by IgG adsorbed to hydrophilic and hydrophobic glass surfaces. Clin Exp Immunol 1997; 109:204-10.
46. 46 Sheterline P, Rickard JE. The cortical actin filament network of neutrophil leucocytes during phagocytosis and chemotaxis. In: Hallet MB, ed. The neutrophil: cellular biochemistry and physiology boca raton. Florida, USA: CRC Press, 1989:141-65.
47. 47 Takemura R, Stenberg P, Bainton D, Werb Z. Rapid distribution of elathrin onto macrophage plasma mambranes in response to Fc receptor-ligand interaction during frustrated phagocytosis. J Cell Biol 1986; 102:55-69.
48. 48 Moura ACN, Modolell M, Mariano M. Down-regulatory effect of Mycobacterium leprae cell wall lipids on phagocytosis, oxidative respiratory burst and tumour cell killing by mouse bone marrow derived macrophages. Scand J Immunol 1997; 46:500-5.